A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 82,531 shares of EW stock, worth $5.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
82,531
Previous 85,692 3.69%
Holding current value
$5.4 Million
Previous $8.19 Million 6.9%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$84.3 - $94.31 $266,472 - $298,113
-3,161 Reduced 3.69%
82,531 $7.62 Million
Q1 2024

Apr 15, 2024

BUY
$72.54 - $95.56 $420,877 - $554,439
5,802 Added 7.26%
85,692 $8.19 Million
Q4 2023

Jan 30, 2024

BUY
$61.71 - $77.76 $71,583 - $90,201
1,160 Added 1.47%
79,890 $6.09 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $4.97 Million - $6.7 Million
71,794 Added 1035.09%
78,730 $5.45 Million
Q2 2023

Jul 21, 2023

BUY
$81.41 - $94.33 $98,261 - $113,856
1,207 Added 21.07%
6,936 $654,000
Q1 2023

Apr 25, 2023

BUY
$74.26 - $84.51 $425,435 - $484,157
5,729 New
5,729 $473,000
Q3 2022

Oct 17, 2022

BUY
$82.37 - $107.29 $1.18 Million - $1.54 Million
14,320 New
14,320 $1.21 Million
Q2 2022

Jul 18, 2022

SELL
$86.5 - $128.27 $4.59 Million - $6.81 Million
-53,093 Closed
0 $0
Q1 2022

Apr 18, 2022

BUY
$101.96 - $128.34 $307,511 - $387,073
3,016 Added 6.02%
53,093 $6.39 Million
Q4 2021

Feb 08, 2022

SELL
$106.37 - $130.68 $2.03 Million - $2.5 Million
-19,100 Reduced 27.61%
50,077 $5.47 Million
Q3 2021

Nov 03, 2021

BUY
$102.91 - $122.75 $7.12 Million - $8.49 Million
69,177 New
69,177 $8.09 Million
Q4 2019

Feb 05, 2020

SELL
$71.7 - $82.09 $672,546 - $770,004
-9,380 Closed
0 $0
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $577,339 - $707,533
9,380 New
9,380 $2.13 Million
Q2 2019

Aug 02, 2019

SELL
$55.74 - $64.41 $342,689 - $395,992
-6,148 Closed
0 $0
Q1 2019

Apr 30, 2019

BUY
$47.89 - $64.05 $294,427 - $393,779
6,148 New
6,148 $1.11 Million
Q3 2018

Nov 02, 2018

SELL
$45.7 - $58.03 $385,251 - $489,192
-8,430 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$42.45 - $51.3 $357,853 - $432,459
8,430 New
8,430 $1.24 Million
Q1 2018

Apr 26, 2018

SELL
$37.19 - $47.45 $652,089 - $831,988
-17,534 Closed
0 $0
Q4 2017

Jan 19, 2018

SELL
$33.79 - $39.39 $59,369 - $69,208
-1,757 Reduced 9.11%
17,534 $2.12 Million
Q3 2017

Oct 18, 2017

BUY
$36.29 - $38.83 $700,070 - $749,069
19,291
19,291 $2.15 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.